Biblio
Export 2045 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is M [Clear All Filters]
“Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 1, pp. 1-20, 2024.
, “Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 2, pp. 623-637., 2024.
, “Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 2, pp. 623-637., 2024.
, “ApoE ε4-dependent Alteration of CXCR3 CD127 CD4 T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251320123, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Chronic gingivitis increases the risk of early-onset Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251336259, 2025.
, “Factors associated with a healthy diet and willingness to change dietary behavior in older adults at increased risk of dementia.”, J Alzheimers Dis, p. 13872877251330296, 2025.
, “Interactive effects of ɛ4 status and vascular burden on white matter microstructural integrity in aging with and without neurocognitive decline.”, J Alzheimers Dis, p. 13872877251320660, 2025.
, “Iron chelation by oral deferoxamine treatment decreased brain iron and iron signaling proteins.”, J Alzheimers Dis, p. 13872877241313031, 2025.
, “Leptin, adiponectin, body mass index, and incident cognitive impairment.”, J Alzheimers Dis, p. 13872877251326060, 2025.
, “Lipopolysaccharides from indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251326879, 2025.
, “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
, “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
, “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
, “Sex-specific effects of apolipoprotein E ε4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period.”, J Alzheimers Dis, p. 13872877241313066, 2025.
, “White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251316516, 2025.
,